Found: 7
Select item for more details and to access through your institution.
Evaluation of clinical and biological prognostic factors in relapsed or refractory diffuse large B-cell lymphoma patients after previous treatment with rituximab and chemotherapy: results of the PRO-R-IPI study.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Safety and efficacy of single-agent bendamustine after failure of brentuximab vedotin in patients with relapsed or refractory hodgkin's lymphoma: experience with 27 patients.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Oral Debio1143 (AT406), an antagonist of inhibitor of apoptosis proteins, combined with daunorubicin and cytarabine in patients with poor-risk acute myeloid leukemia--results of a phase I dose-escalation study.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Phase I study of S-trans, trans-farnesylthiosalicylic acid (salirasib), a novel oral RAS inhibitor in patients with refractory hematologic malignancies.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Three newly approved drugs for chronic lymphocytic leukemia: incorporating ibrutinib, idelalisib, and obinutuzumab into clinical practice.
- Published in:
- 2015
- By:
- Publication type:
- journal article
A phase II, single-arm, open-label, multicenter study to evaluate the efficacy and safety of P276-00, a cyclin-dependent kinase inhibitor, in patients with relapsed or refractory mantle cell lymphoma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
A phase I study of midostaurin and azacitidine in relapsed and elderly AML patients.
- Published in:
- 2015
- By:
- Publication type:
- journal article